ESC 365
Menu
Home
Search
Live & Upcoming Events
About
Create an account
Sign in
Back
Open Access
Anticoagulation management in non-valvular atrial fibrillation: optimising patient outcomes
Event:
ESC CONGRESS 2020 - The Digital Experience
Topic:
Oral Anticoagulation
Session type:
Industry Q&A session
Sponsored by Bristol Myers Squibb and Pfizer
Date:
30 August 2020
Time:
12:45 - 13:45
Congress Session
This content is currently on OPEN ACCESS
Sign in to view the resources
0
4
presentations
in this session
Anticoagulation in non-valvular atrial fibrillation: Current landscape.
Speaker:
Professor S. Hohnloser (Frankfurt, DE)
Access
Video
0
Improving outcomes for non-valvular atrial fibrillation patients with acute coronary syndrome and/or requiring percutaneous coronary intervention.
Speaker:
Professor R. Lopes (Durham, US)
Access
Video
0
Improving patient outcomes through atrial fibrillation screening: Current situation and future directions.
Speaker:
Doctor E. Svennberg (Stockholm, SE)
Access
Video
0
Questions and Answers: Are we closing knowledge and practice gaps?
Speaker:
Professor S. Hohnloser (Frankfurt, DE)
Speaker:
Professor R. Lopes (Durham, US)
Speaker:
Doctor E. Svennberg (Stockholm, SE)
Access
Video
0
6
speakers
from this session
Professor Stefan H Hohnloser
Johann Wolfgang Goethe University, Frankfurt (Germany)
27
presentations
1
follower
Professor Renato Lopes
Duke University Medical Center, Duke Clinical Research Institute, Durham (United States of America)
20
presentations
0
follower
Doctor Emma Svennberg
Karolinska Institute, Stockholm (Sweden)
16
presentations
4
followers
Professor Stefan H Hohnloser
Johann Wolfgang Goethe University, Frankfurt (Germany)
27
presentations
1
follower
Professor Renato Lopes
Duke University Medical Center, Duke Clinical Research Institute, Durham (United States of America)
20
presentations
0
follower
Doctor Emma Svennberg
Karolinska Institute, Stockholm (Sweden)
16
presentations
4
followers
This platform is supported by